Nissay Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.7M Buy
321,933
+10,412
+3% +$1.15M 0.21% 81
2025
Q1
$34.9M Buy
311,521
+27,278
+10% +$3.06M 0.23% 73
2024
Q4
$26.8M Buy
284,243
+14,009
+5% +$1.32M 0.16% 93
2024
Q3
$22.7M Buy
270,234
+21,211
+9% +$1.78M 0.14% 110
2024
Q2
$17.1M Buy
249,023
+27,046
+12% +$1.86M 0.11% 120
2024
Q1
$16.3M Buy
221,977
+49,153
+28% +$3.6M 0.11% 125
2023
Q4
$14M Buy
172,824
+14,049
+9% +$1.14M 0.11% 119
2023
Q3
$11.9M Buy
158,775
+9,911
+7% +$743K 0.11% 124
2023
Q2
$11.5M Sell
148,864
-709
-0.5% -$54.6K 0.1% 128
2023
Q1
$12.4M Sell
149,573
-4,801
-3% -$398K 0.11% 121
2022
Q4
$13.3M Buy
154,374
+1,347
+0.9% +$116K 0.13% 116
2022
Q3
$9.44M Buy
153,027
+5,617
+4% +$347K 0.1% 128
2022
Q2
$9.11M Buy
147,410
+606
+0.4% +$37.5K 0.09% 128
2022
Q1
$8.73M Buy
146,804
+2,748
+2% +$163K 0.08% 154
2021
Q4
$10.5M Buy
144,056
+3,182
+2% +$231K 0.08% 149
2021
Q3
$9.84M Sell
140,874
-3,718
-3% -$260K 0.08% 141
2021
Q2
$9.96M Buy
144,592
+2,860
+2% +$197K 0.09% 142
2021
Q1
$9.16M Sell
141,732
-4,015
-3% -$259K 0.09% 141
2020
Q4
$8.49M Sell
145,747
-7,060
-5% -$411K 0.13% 138
2020
Q3
$9.66M Sell
152,807
-21,444
-12% -$1.36M 0.16% 113
2020
Q2
$13.4M Buy
174,251
+8,208
+5% +$632K 0.26% 95
2020
Q1
$12.4M Buy
166,043
+1,049
+0.6% +$78.4K 0.32% 84
2019
Q4
$10.7M Sell
164,994
-5,903
-3% -$384K 0.24% 104
2019
Q3
$10.8M Buy
170,897
+5,396
+3% +$342K 0.26% 94
2019
Q2
$11.2M Sell
165,501
-6,515
-4% -$440K 0.28% 89
2019
Q1
$11.2M Sell
172,016
-7,965
-4% -$518K 0.3% 81
2018
Q4
$11.3M Sell
179,981
-1,634
-0.9% -$102K 0.34% 72
2018
Q3
$14M Sell
181,615
-30,076
-14% -$2.32M 0.38% 62
2018
Q2
$15M Sell
211,691
-34,131
-14% -$2.42M 0.44% 54
2018
Q1
$18.5M Sell
245,822
-22,283
-8% -$1.68M 0.58% 40
2017
Q4
$19.2M Buy
+268,105
New +$19.2M 0.58% 43